Kestrel Therapeutics Inc.

Boston, MA · Founded 2020 · CIK 0001853373 · Biotech · Private

Targeted cancer therapeutic molecules

kestreltherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$21M
4 Form D · Aug 2025
14 months since last filing
Contracts
—
No federal contracts on record
Patents
16
0 granted · 16 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$228,000
Private capital raisedForm D · SEC$7,500,000
Private capital raisedForm D · SEC$8,000,000
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2470Rocket Pharmaceuticals Ltd.—$28M
2471BIOSTRATEGIES LC——
2472Fulgent Pharma LLC—$5.4M
2473Kestrel Therapeutics Inc.—$21M
2474FIBRONOX, L.L.C.——
2475Aulos Bioscience, Inc.—$20M
2476Surf Bio, Inc.—$16M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Frank HaluskaDirector · Executive Officer
  • Omar KhalilDirector
  • Denis PatrickDirector
  • Andrew PhillipsDirector
  • Nicholas SaccomanoDirector
  • Barbara SosnowskiDirector

Patents

USPTO · 0 granted of 16
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication
  • Ras Inhibitors And Methods Of Use Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.